7 Feb 2023

NFC & RFID Technologies: Adding Value to Drugs and Medical Devices with Connectivity

Connecting medication and medical devices to the internet can enhance product protection, improve patient safety and outcomes, and optimize processes along complex supply chains. NFC-RFID technologies are increasingly used to provide connectivity benefits more securely and efficiently, ensuring that pharma products are safer and more effective to use. Applications include reliable counterfeit and integrity protection, automated supply chain and inventory management, simplified drug delivery and self-medication, and more. As a prominent technology leader NXP strives to build a smarter world on secure connections, with designs that connect, sense, think and act intelligently, all to enhance people’s lives. Visit our workshop and find out how our multifunctional NFC-RFID solutions bring added safety, security and connectivity benefits to manufacturers, healthcare providers, and patients alike.

Content provided by our supplier

NXP Semiconductors Germany GmbH

  • DE
  • 2022
    On CPHI since

Other Content from NXP Semiconductors Germany GmbH (1)

  • Webinar RFID and NFC: The Edge Technologies Improving Product Safety, Patient Outcomes and Process Efficiency

    Edge Technologies, based on RFID (Radio Frequency Identification) and NFC (Near Field Communication) give medical devices and medicines a unique digital identity, and automatically read, sense, store and process, data locally on products, whilst enabling tracking and complex processing in the cloud or private network. The results are optimized logistics, increased product safety, improved patient outcomes and reliable supply chain protection. NXP, a market leader in security and connectivity solutions, has a successful track record of providing trusted solutions to the healthcare industry, to help enhance people’s lives. Visit our workshop and find out about latest solutions in connected pharma packaging and drug delivery devices, for use in hospitals, clinical trials and patient self-care.